Skip to main content
SpringerLink
Log in

Prophylaxe bei nicht chirurgischen Patienten aus Sicht eines Herstellers

  • Chapter
Prävention von Thrombosen und Embolien in der Inneren Medizin

  • 519 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 9.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur zu Teil III (Kapitel 11–14)

  • Aquino JP, Gambier A, Ducros J (1990) Prevention of thromboembolic accidents in elderly subjects with Fraxiparine. In: Bounameaux H, Samana MM, Ten Cate JW (eds) Fraxiparine, 2nd international symposium. Recent pharmacological and clinical data. Schattauer, Stuttgart, New York, pp 51–54

    Google Scholar 

  • Beer JH (1992) Prophylaxe der venösen Thrombembolie bei internistischen Patienten. Therapeutische Umschau 49: 825–832

    PubMed  CAS  Google Scholar 

  • Belch JJ, Lowe GDO, Ward AG, Forbes CD, Prentice CRM (1981) Prevention of deep vein thrombosis in medical patients by low-dose heparin. Scott Med J 26: 115–117

    PubMed  CAS  Google Scholar 

  • Bergmann JF, Neuhart E (1996) A multicenter randomized double-blind study of Enoxaparin compared with unfractionated Heparin in the prevention of venous thromboembolic disease in elderly in-patients bedridden for acute medical illness. Thrombosis Haemostasis 76: 529–534

    CAS  Google Scholar 

  • Bergqvist D, Bergentz SE (1990) Diagnosis of deep vein thrombosis. World J Surg 14: 679–687

    Article  PubMed  CAS  Google Scholar 

  • Cade JF, Andrews JT, Stubbs AE (1982) Comparison of sodium and calcium heparin inprevention of venous thromboembolism. Aust N Z J Med 12: 501–504

    PubMed  CAS  Google Scholar 

  • Cohen AT (2003) ARIXTRA® (fondaparinux sodium) significantly lowers the risk of venous thromboembolism in acutely ill medical patients; Presented at the XIXth Congress of the International Society on Thrombosis and Haemostasis, Birmingham, UK, July 14, 2003

    Google Scholar 

  • Collins R, Scrimgeour A, Yusuf S, Peto R (1988) Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery. N Engl J Med 318: 1162–1173

    Article  PubMed  CAS  Google Scholar 

  • Cooperberg AA, Teitelbaum J (1960) The concentration of antihaemophilic globulin (AHG) related to age. Br J Haematol 6: 281–287

    PubMed  CAS  Google Scholar 

  • Dahan R, Houlbert D, Caulin C (1986) Prevention of deep vein thrombosis in elderly medical in-patients by a low molecular weight heparin. Haemostasis 16: 159–164

    PubMed  CAS  Google Scholar 

  • Flanc C, Kakkar VV, Clarke MB (1969) Postoperative deep-vein thrombosis. Effect of intensive prophylaxis. Lancet 1: 477–478

    PubMed  CAS  Google Scholar 

  • Fraisse F, Holzapfel L, Couland JM, Simonneau G, Bedock B, Feissel M, Herbecq P Pordes R, Poussel JF, Roux L (2000) Nadroparin in the prevention of deep vein thrombosis in acute decompensated COPD. Am J Respir Crit Care Med 161: 1109–1114

    PubMed  CAS  Google Scholar 

  • Gallus AS, Hirsh J, Tutle RJ, Trebilcock R, O’Brien SE, Carroll JJ, Minden JH, Hudecki SM (1973) Small subcutaneous doses of heparin in prevention of venous thrombosis. N Engl J Med 288: 545–551

    Article  PubMed  CAS  Google Scholar 

  • Gardlund B (1996) Randomised, controlled trial of low-dose Heparin for prevention of fatal pulmonary embolism in patients with infectious diseases. Lancet 347: 1357–1361

    PubMed  CAS  Google Scholar 

  • Halkin H, Goldberg J, Modan M, Modan B (1982) Reduction of mortality in general medical in-patients by low-dose heparin prophylaxis. Ann Intern Med 96: 561–565

    PubMed  CAS  Google Scholar 

  • Harenberg J, Kallenbach B, Martin U (1990) Randomised controlled study of heparin and low molecular weight heparin for prevention of deep-vein thrombosis in medical patients. Thromb Res 59: 639–950

    Article  PubMed  CAS  Google Scholar 

  • Harenberg J, Roebruck P, Heene DL (1996) Subcutaneous low-molecular-weight heparin versus standard heparin and the prevention of thromboembolism in medical inpatients. The Heparin Study in Internal Medicine Group. Haemostasis 26: 127–139

    PubMed  CAS  Google Scholar 

  • Havig O (1977) Deep vein thrombosis and pulmonary embolism an autospy study with multiple regression analysis of possible risk factors. Acta Chirurg Scand 478: 1–120

    CAS  Google Scholar 

  • Hillbom M et al. (2002) Enoxaparin vs heparin for prevention of deep-vein thrombosis in acute ischaemic stroke: a randomized, double-blind study. Acta Neurol Scand 106: 84–92

    Article  PubMed  CAS  Google Scholar 

  • Hills NH, Pflug JJ, Jeyasingh K, Boardman L, Calnan JS (1972) Prevention of deep vein thrombosis by intermittent pneumatic compression of calf. Br Med J 1: 131–135

    PubMed  CAS  Google Scholar 

  • Ibarra-Perez C, Lau-Cortes E, Colmenero-Zubiate S (1988) Prevalence and prevention of deep venous thrombosis of the lower extremities in high risk pulmonary patients. Angiology 39: 503–513

    Google Scholar 

  • Jung W, Fridrich R, Duckert F, Gruber UF (1975) Der Radiofibrinogentest zur Diagnose frischer tiefer Venenthrombosen. Schweiz Med Wschr 105: 391–398

    PubMed  CAS  Google Scholar 

  • Kakkar VV (1975) Prevention of fatal postoperative pulmonary embolism by low doses of heparin. An international multicentre trial. Lancet 2: 45–51

    Google Scholar 

  • Kakkar VV, Corrigan TP, Fossard DP, Sutherland I, Thirwell J (1977) Prevention of Fatal Postoperative pulmonary embolism by low doses of heparin. Reappraisal of results of international multicentre trial. Lancet 1: 567–569

    PubMed  CAS  Google Scholar 

  • Kleber FX, Witt C, Vogel G, Koppenhagen K, Schomaker U, Flosbach CW, THE-PRINCE Study Group (2003) Randomized comparison of enoxaparin with unfractionated heparin for the prevention of venous thromboembolism in medical patients with heart failure or severe respiratory disease. Am Heart J 145: 614–621

    Article  PubMed  CAS  Google Scholar 

  • Lechler E, Schramm W, Flosbach CW (1996) The venous thrombotic risk in non-surgical patients: epidemiological data and efficacy/safety profile of a low-molecular-weight heaprin (enoxaparin). The Prime Study Group. Haemostasis 26[Suppl 2]: 49–56

    PubMed  CAS  Google Scholar 

  • Leizorovicz A (2003) PREVENT: Prospective evaluation of Dalteparin efficacy for prevention of VTE in immobilized patients trial; Presented at the 32nd Annual Congress of the Society of Critical Care Medicine, San Antonio, Texas, USA, Jan 31

    Google Scholar 

  • Leizorovicz A, Cohen AT, Turpie AGG, Olsson CG, Vaitkus PT, Goldhaber SZ (2003) A randomized placebo controlled trial of dalteparin for the prevention of venous thromboembolism in 3706 acutely Ill medical patients: the PREVENT medical thromboprophylaxis study. J Thromb Haemostasis 1[Suppl 1] OC 396

    Google Scholar 

  • Leizorovicz A, Haugh MC, Chapuis FR, Samama MM, Boissel JP (1992) Low molecular weight heparin in prevention of perioperative thrombosis. BMJ 305: 913–920

    Article  PubMed  CAS  Google Scholar 

  • Manciet G, Vergnes C, Vaissie JJ, Boisseau MR (1990) Etude de l’efficacite et de la tolerance de Fraxiparine administree au long cours chez le sujet age. In: Bounameaux H, Samana MM, Ten Cate JW (eds) Fraxiparine, 2nd international symposium. Recent pharmacoloigcal and clinical data. Schattauer, Stuttgart, New York, pp 55–59

    Google Scholar 

  • Maurer BJ, Wray R, Shillingford JP (1971) Frequency of venous thrombosis after myocardial infarction. Lancet 2: 1385–1387

    PubMed  CAS  Google Scholar 

  • McFarlane AS (1958) Efficient trace-labelling of proteins with iodine. Nature 182: 53

    PubMed  CAS  Google Scholar 

  • Miller RR, Lies JE, Carretta RF, Wampold DB, DeNardo GL, Kraus JF, Amsterdam EA, Mason DT (1976) Prevention of lower extremity venous thrombosis by early mobilization. Confirmation in patients with acute myocardial infarction by 125I-fibrinogen uptake and venography. Ann Intern Med 84: 700–703

    PubMed  CAS  Google Scholar 

  • Mismetti P, Laporte-Simitsidis S, Tardy B, Cucherat M, Buchmuller A, Juillard-Delsart D, Decousus H (2000) Prevention of venous thromboembolism in internal medicine with unfractionated or low-molecular-weight heparins: a meta-analysis of randomised clinical trials. Thromb Haemost 83: 14–19

    PubMed  CAS  Google Scholar 

  • Murray TS, Lorimer AR, Cox FC, Lawrie TDV (1970) Leg-vein thrombosis following myocardial infarction. Lancet 2: 792–793ii

    PubMed  CAS  Google Scholar 

  • Negus D, Pinto DJ, Le Quesne LP, Brown N, Chapman M (1968) 125-I-labelled fibrinogen in the diagnosis of deep-vein thrombosis and its correlation with phlebography. Br J Surg 55: 835–839

    PubMed  CAS  Google Scholar 

  • Nicolaides AN, Kakkar VV, Field ES, Fish P (1972) Optimal electrical stimulus for prevention of deep vein thrombosis. Br Med J 3: 756–758

    Article  PubMed  CAS  Google Scholar 

  • Nurmohamed MT, Rosendaal FR, Buller HR, Dekker E, Hommes DW, Vandenbroucke JP, Briet E (1992) Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis. Lancet 340: 152–156

    Article  PubMed  CAS  Google Scholar 

  • Poniewierski M, Barthels M, Kuhn M, Poliwoda F (1988) Effectiveness of low molecular weight heparin in the prevention of thromboembolims in internal medicine patients. Med Klin 83: 241–245

    PubMed  CAS  Google Scholar 

  • Riedler GF (1977) Thromboseprophylaxe in der Inneren Medizin. Therapeutische Umschau 34: 363–367

    PubMed  CAS  Google Scholar 

  • Samama MM, Cohen AT, Darmon JY, Desjardins L, Eldor A, Janbon C, Leizorovicz Nguyen H, Olsson CG, Turpie AG, Weislinger N for the Study Group (1999) A comparison od enoxaparin with placebo for the prevention of venous thrombembolism in acutely ill medical patients. N Engl J Med 341: 793–800

    Article  PubMed  CAS  Google Scholar 

  • Schuurman B, den Heijer M, Nijs AM (2000) Thrombosis prophylaxis in hospitalised medical patients: does prophylaxis in all patients make sense? Neth J Med M 56: 171–176

    CAS  Google Scholar 

  • Stieger R, Gruber UF (1981) Prophylaxe tiefen Venenthrombosen in der inneren Medizin Schweiz Med Wochenschr 111: 716–722

    CAS  Google Scholar 

Download references

Authors
  1. C. Kienitz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. Linße
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Institut für Experimentelle Onkologie und Therapieforschung, Ismaninger Str. 22, 81675, München

    Sylvia Haas (Professor, Dr. med.) (Professor, Dr. med.)

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

Kienitz, C., Linße, B. (2005). Prophylaxe bei nicht chirurgischen Patienten aus Sicht eines Herstellers. In: Haas, S. (eds) Prävention von Thrombosen und Embolien in der Inneren Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-27118-X_14

Download citation

  • DOI: https://doi.org/10.1007/3-540-27118-X_14

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-22563-8

  • Online ISBN: 978-3-540-27118-5

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation